We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+10.11%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$24.6B
AUM Growth
-$539M
(-2.1%)
Cap. Flow
-$2.74B
Cap. Flow
% of AUM
-11.15%
Top 10 Holdings %
Top 10 Hldgs %
16.61%
Holding
1,387
New
97
Increased
426
Reduced
465
Closed
225
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$66.4M |
| 2 |
Microsoft
MSFT
|
+$52.8M |
| 3 |
Mastercard
MA
|
+$39.5M |
| 4 |
Linde
LIN
|
+$28.7M |
| 5 |
Ferrari
RACE
|
+$27.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$160M |
| 2 |
iShares S&P 500 Growth ETF
IVW
|
+$106M |
| 3 |
iShares Morningstar Growth ETF
ILCG
|
+$105M |
| 4 |
Vanguard Morningstar Growth ETF
VUG
|
+$104M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$89.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.52% |
| 2 | Healthcare | 17.23% |
| 3 | Financials | 12.29% |
| 4 | Consumer Discretionary | 11.39% |
| 5 | Industrials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Deutsche Bank
DB
$72.1B
| $658K | ﹤0.01% |
84,600
-5,297
| -6% | -$39.7K |
|
|
BELFB
927
Bel Fuse Inc Class B
BELFB
$3.39B
| $654K | ﹤0.01% |
31,900
+9,900
| +45% | +$163K |
|
|
PLAN
928
DELISTED
Anaplan, Inc.
PLAN
| $650K | ﹤0.01% |
+12,400
| New | +$615K |
|
|
JNCE
929
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $643K | ﹤0.01% |
+73,600
| New | +$398K |
|
|
SNCR
930
DELISTED
Synchronoss Technologies
SNCR
| $640K | ﹤0.01% |
14,967
+11,023
| +279% | +$489K |
|
|
GCAP
931
DELISTED
Gain Capital Holdings, Inc.
GCAP
| $638K | ﹤0.01% |
161,400
| – | – |
|
932
Arch Capital
ACGL
$33.1B
| $637K | ﹤0.01% |
14,858
+437
| +3% | +$18.1K |
|
933
Markel Group
MKL
$22.1B
| $637K | ﹤0.01% |
558
+20
| +4% | +$22.8K |
|
934
Resideo Technologies
REZI
$2.83B
| $635K | ﹤0.01% |
53,169
-285,872
| -84% | -$3.25M |
|
935
Kennametal
KMT
$2.27B
| $634K | ﹤0.01% |
17,200
-211,300
| -92% | -$7.07M |
|
936
Open Text
OTEX
$5.67B
| $623K | ﹤0.01% |
14,158
-84,300
| -86% | -$3.54M |
|
|
ECOM
937
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $606K | ﹤0.01% |
67,000
| – | – |
|
938
Global Industrial
GIC
$1.52B
| $601K | ﹤0.01% |
23,900
-1,700
| -7% | -$39.6K |
|
|
AAN.A
939
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $600K | ﹤0.01% |
10,500
-10,300
| -50% | -$589K |
|
940
Skyworks Solutions
SWKS
$12.9B
| $597K | ﹤0.01% |
4,937
-5
| -0.1% | -$491 |
|
|
BBBY
941
DELISTED
Bed Bath & Beyond Inc
BBBY
| $596K | ﹤0.01% |
34,500
-25,700
| -43% | -$360K |
|
942
SSR Mining
SSRM
$7.18B
| $595K | ﹤0.01% |
30,900
+14,600
| +90% | +$227K |
|
943
Chunghwa Telecom
CHT
$35B
| $590K | ﹤0.01% |
16,000
| – | – |
|
944
Primerica
PRI
$8.98B
| $588K | ﹤0.01% |
4,500
-7,300
| -62% | -$943K |
|
945
LGI Homes
LGIH
$1.14B
| $586K | ﹤0.01% |
+8,300
| New | +$632K |
|
946
Strategy Inc
MSTR
$50.1B
| $585K | ﹤0.01% |
+41,000
| New | +$610K |
|
947
Match Group
MTCH
$10B
| $583K | ﹤0.01% |
7,100
-12,700
| -64% | -$924K |
|
948
Altria Group
MO
$117B
| $582K | ﹤0.01% |
11,651
| – | – |
|
949
LendingTree
TREE
$373M
| $577K | ﹤0.01% |
1,900
-800
| -30% | -$265K |
|
950
Kosmos Energy
KOS
$1.71B
| $570K | ﹤0.01% |
100,000
| – | – |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q4 2019 Portfolio in Review
As of Q4 2019, Axa held 1,387 positions worth $24.6B, down 2.1% from $25.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Axa withdrew a net $2.74B in Q4 2019, closing 225 positions and reducing 465 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $160M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Axa opened a new position in Baker Hughes worth $26.1M.
- Axa's largest Q4 2019 buy was Baker Hughes: 1,017,347 shares worth $26.1M.
- Axa added most to Pfizer in Q4 2019, an estimated $66.4M increase.
- Axa's biggest Q4 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $89.1M.
- Axa fully exited iShares Russell 1000 Growth ETF in Q4 2019, selling an estimated $160M.
- Axa's ten largest holdings make up 17% of its $24.6B portfolio in Q4 2019.
- Axa opened 97 new positions and closed 225 in Q4 2019.
- Axa's portfolio value fell 2.1% quarter-over-quarter to $24.6B.
Based on Axa's 13F filing for Q4 2019, filed 18 Feb 2020.